Previous 10 | Next 10 |
The following slide deck was published by Neos Therapeutics, Inc. in conjunction with their 2019 Q3 earnings Read more ...
Neos Therapeutics (NASDAQ: NEOS ): Q3 GAAP EPS of -$0.04 beats by $0.07 . More news on: Neos Therapeutics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
DALLAS and FORT WORTH, Texas, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company utilizing its novel microparticle delivery technology to develop and manufacture central nervous system-focused products, today reported financia...
DALLAS and FORT WORTH, Texas, Nov. 01, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company utilizing its novel microparticle delivery technology to develop and manufacture central nervous system (CNS)-focused products, today announced ...
Neos Therapeutics, Inc. (NEOS) is a commercial-stage pharma company that uses a unique delivery mechanism to deliver treatments in the ADHD space. The company has 3 approved products: Adzenys XR-ODT ® (amphetamine), an extended-release orally disintegrating tablet. Cotempla XR-ODT ...
I wrote about Neos Therapeutics ( NEOS ) six months ago and suggested fundamentals are improving, but with some caveats and that the company faces a tough road ahead. Since that article, the stock dropped more than 50% and recovered some of the lost ground in the last two months. I have to...
DALLAS and FORT WORTH, Texas, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company utilizing its novel microparticle delivery technology to develop and manufacture central nervous system (CNS)-focused products, today announced ...
The following slide deck was published by Neos Therapeutics, Inc. in conjunction with this Read more ...
DALLAS and FORT WORTH, Texas, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company utilizing its novel microparticle delivery technology to develop and manufacture central nervous system (CNS)-focused products, today announced t...
Neos Therapeutics, Inc. (NEOS) Q2 2019 Earnings Conference Call August 08, 2019, 08:30 AM ET Company Participants Jerry McLaughlin - CEO Richard Eisenstadt - CFO Conference Call Participants Carvey Leung - Cantor Fitzgerald Ken Cacciatore - Cowen & Company Jason Butle...
News, Short Squeeze, Breakout and More Instantly...
Neos Therapeutics Inc. Company Name:
NEOS Stock Symbol:
NASDAQ Market:
Neos Therapeutics Inc. Website:
Penny Stock News Triggers Momentum In These Cheap Stocks When it comes to penny stocks, there are plenty of different catalysts to consider. You could look for general market trends or sector/industry-based themes. However, these are more along the line of technical catalysts. On the ot...
– The Neos Therapeutics Board of Directors recommend stockholders vote “FOR” the transaction in advance of the virtual special meeting scheduled for March 18, 2021 at 10:00 a.m. Eastern Time – – Stockholders are encouraged to vote, no matt...
– The Neos Therapeutics Board of Directors recommend stockholders vote “FOR” the transaction in advance of the virtual special meeting scheduled for March 18, 2021 at 10:00 a.m. Eastern Time – – Stockholders are encouraged to vote, no matt...